0 likes | 10 Views
Global blood-brain barrier transport drugs market refers to the market for drugs that are designed to cross the blood-brain barrier (BBB), which is a complex network of blood vessels and cells that protect the brain from harmful substances. The Blood Brain Barrier Transport Drugs also acts as a barrier for many drugs, making it difficult for them to reach the brain.
E N D
Blood Brain Barrier Transport Drugs Market Update: Fast Change Strategies for 2023-2030 Powered by GQ Research
Market Definition & Scope “The blood-brain barrier (BBB) refers to a highly selective and protective barrier that separates the bloodstream from the brain's extracellular fluid. It is a crucial physiological structure that plays a vital role in maintaining the stability and integrity of the brain's internal environment. The BBB is formed by specialized endothelial cells lining the blood vessels in the brain, and it is characterized by tight junctions between these cells, which restrict the passage of many substances from the blood into the brain.” Powered by GQ Research
Market Technologies • Trojan Horse Approach • Bispecific Antibody RMT Approach • Increasing Permeability of BBB • Passive Diffusion Powered by GQ Research
Market Application • Alzheimer’s Disease • Epilepsy • Others Powered by GQ Research
Key Players • Some of the key players profiled in the study are - • AngiochemInc • OssianixInc • Armagen Technologies Inc. • BiOasis Technologies Inc. • Iproteos S.L. • Alzinova • AlzProtect • BBB Therapeutics • ConteraPharma • EIP Pharma Powered by GQ Research
Regions • If opting for the Global version of Agriculture Sensors Market; then the below country analysis would be included: • North America (the USA, Canada, and Mexico) • Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe) • Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC) • South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.) • The Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Powered by GQ Research
Sample Report “Global Blood Brain Barrier Transport Drugs Market size was USD 612.67 Million in 2022 and it is expected to grow to USD 1224.46 Million in 2030 with a CAGR of 8.92% in the 2023-2030 period.” Get free access to sample report @ https://gqresearch.com/request-sample/008 Powered by GQ Research
Contact Us Contact Us: GQ ResearchPhone: +1 614 602 2897info@gqresearch.com Powered by GQ Research